2417649-33-1

Directory

2417649-33-1 Structure

Identification	Back Directory
[Name] Iparomlimab
[CAS] 2417649-33-1
[Synonyms] Iparomlimab Research Grade Iparomlimab (DHH02232)

Hazard Information	Back Directory
[Uses] Iparomlimab is an anti-human PD-1/CD279/PDCD1 IgG4κ antibody. Iparomlimab also targets to human monoclonal PSB103 γ4-chain, disulfided with human monoclonal PSB103 κ-chain to form a dimer. Iparomlimab can be used for Oncology research[1].
[References] [1] Iparomlimab. INN number: 11840. IMGT.

2417649-33-1 suppliers list

Company Name:	ShangHai Biochempartner Co.,Ltd
Tel:	17754423994 17754423994
Website:	https://www.biochempartner.com

Company Name:	Guangzhou Hongyuan Chemical Co.,Ltd
Tel:	15817493340
Website:	https://www.chemicalbook.com/ShowSupplierProductsList1222417/0.htm

Company Name:	Wuhan Chemstan Biotechnology Co., Ltd.
Tel:	027-65317797 15926423062
Website:	http://www.chemstan.com/

Company Name:	Wuhan Jingkangen Biomedical Technology Co., Ltd
Tel:	13720134139 086-15871494362 13720134139
Website:	https://www.jknbiochem.com

Company Name:	Changsha Fuzhen Biotechnology Co.，LTD
Tel:	13823398779 13823398779
Website:	www.chemicalbook.com/supplier/25777903/

Company Name:	Wanxin Biotechnology (Jiaxing) Co., LTD
Tel:	0573-83568680 18057391398
Website:

Company Name:	AntibodySystem Laboratories SAS
Tel:	33175446423
Website:	www.antibodysystem.com

Tags:2417649-33-1 Related Product Information

1607793-29-2 1638935-72-4 1635395-25-3 1509928-04-4 195158-85-1 2417124-95-7 1803171-55-2 2259860-24-5

HomePage | Member Companies | Advertising | Contact us | Previous WebSite | MSDS | CAS Index | CAS DataBase | Privacy | Terms | About Us
All products displayed on this website are only for non-medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.
According to relevant laws and regulations and the regulations of this website, units or individuals who purchase hazardous materials should obtain valid qualifications and qualification conditions.

Login